Condition (MeSH)
Neurosyphilis
ClinicalTrials.gov lists 9 trials for Neurosyphilis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
6 of the 9 trials are tagged with Neurosyphilis itself; the rest are tagged with a narrower condition beneath it.
When did Neurosyphilis trials start? (7)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2024 | 2 |
| 2019 | 1 |
| 2018 | 1 |
| 2015 | 1 |
| 2012 | 1 |
| 2008 | 1 |
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Neurosyphilis trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
| Not applicable | 1 |
| Observational | 5 |
How many Neurosyphilis trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 4 |
| Completed | 5 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Neurosyphilis trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| CENTOGENE GmbH Rostock | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Which publications cover Neurosyphilis? (9)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Intrathecal Synthesis Index of Specific Anti-<i>Treponema</i> IgG: a New Tool for the Diagnosis of Neurosyphilis. | Microbiology spectrum | 2022 | Yes |
| Neurosyphilis During Acute HIV Infection: A CNS Immunologic and Virologic Characterization. | Journal of acquired immune deficiency syndromes (1999) | 2019 | Yes |
| Novel predictors of neurosyphilis among HIV-negative syphilis patients with neurological symptoms: an observational study. | BMC infectious diseases | 2017 | Yes |
| Infecting dose and severity of falciparum malaria. | Transactions of the Royal Society of Tropical Medicine and Hygiene | 1995 | Yes |
| Cognitive function, depressive symptoms and syphilis in HIV-positive and HIV-negative individuals. | International journal of STD & AIDS | 2019 | No |
Showing 5 of 9 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.
Not computed for conditions with fewer than 10 trials: drugs tested.